Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy
This study is ongoing, but not recruiting participants.
Study NCT00056576   Information provided by Elan Pharmaceuticals
First Received: March 18, 2003   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsy, Complex Partial
Additional conditions recognized in this trial
Epilepsy
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Epilepsies, Partial
Nervous System Diseases
Interventions listed in this trial
Zonisamide
More general drug interventions related to this trial
Anticonvulsants
Antioxidants
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Elan Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services